Thiazide drug | Dose range |
Number of trials |
Total patients randomized |
N (% males) and N (% females) |
Mean duration (weeks) |
Mean age (years) |
Baseline systolic/diastolic blood pressure mmHg |
Bendrofluazide | 1.25 to 10.0 mg/day | 1 | 257 | 103 (40%) 154 (60%) |
12 weeks | 57 years | 165/102 mmHg |
Chlorthalidone | 12.5 to 100 mg/day | 8* | 1265 | 581 (50.4%) 684 (49.6%) |
7 weeks | 53 years | 163/88 mmHg |
Cyclopenthiazide | 0.05 to 0.50 mg/day | 1 | 53 | 22 (41.5%) 31 (49.6%) |
8 weeks | 57 years | 164/97 mmHg |
Hydrochlorothiazide | 3 to 100 mg/day | 40 | 7560 | 4152 (57%) 3408 (43%) |
8 weeks | 54 years | 155/100 mmHg |
Indapamide | 1 to 5 mg/day | 10 | 2075 | 1018 (48.4%) 1057 (51.6%) |
10 weeks | 58 years | 161/98 mmHg |
Metolazone | 0.5 to 2.0 mg/day | 1 | 105 | 46 (43.8%) 59 (56.2%) |
6 weeks | Not reported | 150/98 mmHg |
Overall | 60 trials | 11,282* |
5922 (53.0%) 5360 (47.0%) |
8 weeks | 55 years | 158/99 mmHg |